29
Views
1
CrossRef citations to date
0
Altmetric
NOVEL HYPOTHESES

Overexpression of CXCR1/CXCR2 on mesenchymal stromal cells may be an effective treatment for acute myocardial infarction

, , &
Pages 990-991 | Published online: 24 Nov 2009

References

  • Dai W, Hale SL, Martin BJ, Kuang J-Q, Dow JS, Wold LE, . Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005; 112:214–23.
  • Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, . Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005; 11:367–8.
  • Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, . Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9:1195–1201.
  • Amsalem Y, Mardor Y, Feinberg MS, Landa N, Miller L, Daniels D, . Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007; 116:I38–45.
  • Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 2005; 39:363–76.
  • Helmuth L. Neuroscience. Stem cells hear call of injured tissue. Science 2000; 290:1479–81.
  • Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, . SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007; 21:3197–207.
  • Kucia M, Dawn B, Hunt G, Guo Y, Wysoczynski M, Majka M, . Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 2004; 95:1191–9.
  • Haider HKh, Jiang S, Idris NM, Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 2008; 103:1300–8.
  • Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y, . Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008; 16:571–9.
  • Zhang D, Fan GC, Zhou X, Zhao T, Pasha Z, Xu M, . Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 2008; 44:281–92.
  • Samanta AK, Oppenheim JJ, Matsushima K. Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 1990; 265:183–9.
  • Baggiolini M, Moser B, Clark-Lewis I. Interleukin-8 and related chemotactic cytokines. The Giles Filley Lecture. Chest 1994; 105:95S–8S.
  • Marx N, Neumann FJ, Ott I, Gawaz M, Koch W, Pinkau T, . Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997; 30:165–70.
  • Chandrasekar B, Smith JB, Freeman GL. Ischemia-reperfusion of rat myocardium activates nuclear factor-B and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001; 103:2296–302.
  • Tarzami ST, Cheng R, Miao W, Kitsis RN, Berman JW. Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death. J Mol Cell Cardiol 2002; 34:209–21.
  • Vandervelde S, van Luyn MJ, Rozenbaum MH, Petersen AH, Tio RA, Harmsen MC. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc Res 2007; 73:783–93.
  • Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, . MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007; 13:587–96.
  • Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, . Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem 2007; 101:135–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.